Further testing is underway in India, and the manufacturer is arranging collaborations with North American drug companies to launch U.S. tests, Dr. Yusuf said in an interview. Asked if the target population for the polypill is the western world or third world, Dr. Yusuf said his target is “the sensible world.”
'The big question is whether you treat the whole world at large at a certain age. That's been proposed.' DR. YUSUF